Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CtDNA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05224596
What this trial is testing

AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-Gastric

Who this might be right for
Cancer
Shanghai Zhongshan Hospital 498
Testing effectiveness (Phase 2)Ended earlyNCT05060003
What this trial is testing

Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection

Who this might be right for
Stage II Melanoma
Washington University School of Medicine 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT07422805
What this trial is testing

Circulating Tumor DNA in Melanoma Patients

Who this might be right for
MelanomaSkin Cancer
Institute of Oncology Ljubljana 176
Not applicableLooking for participantsNCT04417803
What this trial is testing

Interest of Individual Biomarkers From the Identification of Tumor Genotype by High-throughput Molecular Techniques

Who this might be right for
Lymphomas
Centre Hospitalier Universitaire Dijon 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT06070012
What this trial is testing

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Diwakar Davar 44
Not applicableActive Not RecruitingNCT06090162
What this trial is testing

LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin Lymphoma, B Cell
Swiss Cancer Institute 64
Not applicableLooking for participantsNCT07142226
What this trial is testing

Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC

Who this might be right for
Biliary Tract Cancer
CHA University 200
Not applicableLooking for participantsNCT05081024
What this trial is testing

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

Who this might be right for
Rectal AdenocarcinomaStage II Rectal Cancer AJCC v8Stage IIA Rectal Cancer AJCC v8+6 more
OHSU Knight Cancer Institute 50
Not applicableStudy completedNCT03737591
What this trial is testing

The Implication of Plasma ctDNA Methylation Haplotypes in Detecting Colorectal Cancer and Adenomas

Who this might be right for
Colorectal CancerAdenoma
Fudan University 1,138
Not applicableLooking for participantsNCT05788744
What this trial is testing

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Copenhagen University Hospital at Herlev 1,000
Not applicableUnknownNCT05254821
What this trial is testing

Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients

Who this might be right for
Hodgkin Lymphoma
Federico II University 130
Not applicableLooking for participantsNCT05917106
What this trial is testing

Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

Who this might be right for
CarcinomaRenal Cell CarcinomaRCC+2 more
Jinling Hospital, China 450
Not applicableUnknownNCT03771404
What this trial is testing

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT06446557
What this trial is testing

De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer

Who this might be right for
Metastatic Colon Cancer
University Hospital, Rouen 408
Not applicableEnded earlyNCT02370355
What this trial is testing

Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate Carcinoma
University of Southern California 24
Not applicableUnknownNCT03839706
What this trial is testing

Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 20
Not applicableNot Yet RecruitingNCT06649838
What this trial is testing

Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions

Who this might be right for
ImmunotherapyCervical CancerCtDNA+1 more
Peking Union Medical College Hospital 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07004413
What this trial is testing

Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients

Who this might be right for
Colorectal Cancer Metastatic
Charite University, Berlin, Germany 267
Testing effectiveness (Phase 2)Looking for participantsNCT05601505
What this trial is testing

Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaCirculating Tumor DNA
Peking Union Medical College Hospital 470
Testing effectiveness (Phase 2)WithdrawnNCT04611776
What this trial is testing

A Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezolizumab, in Patients Who Are ctDNA Positive After Complete Surgical Resection of Stage IB to Select IIIB Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Hoffmann-La Roche
Next Page